Jordi Sanchez Dahl

Jordi Sanchez Dahl

Auto-generated profile, based on publicly available information

Jordi Sanchez Dahl

Department of Cardiology, Odense University Hospital , Odense

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
JMJulien Magne
Julien Magne
BCBernard Cosyns
Bernard Cosyns
Bogdan PopescuBogdan Popescu
Bogdan Popescu
HCHelle G. Carstensen
Helle G. Carstensen
JDJordi Dahl
Jordi Dahl
EDErwan Donal
Erwan Donal

10 January 2016 in European Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
ABAnn Banke
Ann Banke
MSMorten Schou
Morten Schou
LVLars Videbæk
Lars Videbæk
JMJacob Eifer Møller
Jacob Eifer Møller
CTChristian Torp-Pedersen
Christian Torp-Pedersen
GGGunnar H. Gislason
Gunnar H. Gislason
Aims With improvement in survival of chronic heart failure (HF), the clinical importance of co‐morbidity is increasing. The aim of this study was to assess the incidence and risk of cancer and all‐cause mortality in a large Danish HF cohort. Methods and results A total of 9307 outpatients with verified HF without a prior diagnosis of cancer (27% female, mean age 68 years, 89% with LVEF <45%) were included in the study. A diagnosis of any cancer and all‐cause mortality was obtained from Danish national registries. Outcome was compared with the general Danish population. Overall and type‐specific risk of cancer was analysed in an adjusted Poisson and Cox regression analysis. The 975 diagnoses of cancer in the HF cohort and 330 843 in the background population corresponded to incidence rates per 10 000 patient‐years of 188.9 [95% confidence interval (CI) 177.2–200.6] and 63.0 (95% CI 63.0–63.4), respectively. When stratified by age, incidence rates were increased in all age groups in the HF cohort. Risk of any type of cancer was increased, with an incidence rate ratio of 1.24 (95% CI 1.15–1.33, c < 0.0001). Type‐specific analysis demonstrated an increased hazard ratio for all major types of cancer except for prostate cancer. All‐cause mortality was higher in HF patients with cancer compared with cancer patients from the background population. Conclusions Patients with HF have an increased risk of cancer, which persists after the first year after the diagnosis of HF, and their prognosis is worse compared with that of cancer patients without HF.

1 May 2017 in JACC: Heart Failure
Verified
Journal Article
Closed access
EWEmil Wolsk
Emil Wolsk
RBRine Bakkestrøm
Rine Bakkestrøm
JTJakob Hartvig Thomsen
Jakob Hartvig Thomsen
LBLouise Balling
Louise Balling
MAMads J. Andersen
Mads J. Andersen
FGFinn Gustafsson
Finn Gustafsson

14 August 2023 in JACC
Verified
Journal Article
Closed access
ACAugustin Coisne
Augustin Coisne
PLPatrizio Lancellotti
Patrizio Lancellotti
GHGilbert Habib
Gilbert Habib
MGMadalina Garbi
Madalina Garbi
JDJordi Sanchez Dahl
Jordi Sanchez Dahl
PPPhilippe Pibarot
Philippe Pibarot

1 September 2012 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
JDJordi S. Dahl
Jordi S. Dahl
LVLars Videbæk
Lars Videbæk
MPMikael K. Poulsen
Mikael K. Poulsen
TRTorsten R. Rudbæk
Torsten R. Rudbæk
PPPatricia A. Pellikka
Patricia A. Pellikka
JMJacob E. Møller
Jacob E. Møller
Background—: Global longitudinal systolic strain (GLS) is often reduced in aortic stenosis despite normal ejection fraction. The importance of reduced preoperative GLS on long-term outcome after aortic valve replacement is unknown. Methods and Results—: A total of 125 patients with severe aortic stenosis and ejection fraction >40% scheduled for aortic valve replacement were evaluated preoperatively and divided into 4 groups according to GLS quartiles. Patients were followed up for 4 years. The primary end points were major adverse cardiac events (MACEs) defined as cardiovascular mortality and cardiac hospitalization because of worsening of heart failure; the secondary end point was cardiovascular mortality. MACE and cardiac mortality were significantly increased in patients with lower GLS. Estimated 5-year MACE was increased: first quartile 19% (n=6) / second quartile 20% (n=6) / third quartile 35% (n=11) / fourth quartile 49% (n=15); P =0.04. Patients with increased age, left ventricular hypertrophy, and left atrial dilatation were at increased risk. In Cox regression analysis, after correcting for standard risk factors and ejection fraction, GLS was found to be significantly associated with cardiac morbidity and mortality. In a stepwise Cox model with forward selection, GLS was the sole independent predictor: hazard ratio=1.13 (95% confidence interval, 1.02–1.25), P =0.04. Comparing the overall log likelihood χ 2 of the predictive power of the multivariable model containing GLS was statistically superior to models based on EuroScore, history with ischemic heart disease, and ejection fraction. Conclusions—: In patients with symptomatic severe aortic stenosis undergoing aortic valve replacement, reduced GLS provides important prognostic information beyond standard risk factors. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00294775.

1 January 2019 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
JDJordi S. Dahl
Jordi S. Dahl
JMJulien Magne
Julien Magne
PPPatricia A. Pellikka
Patricia A. Pellikka
EDErwan Donal
Erwan Donal
TMThomas H. Marwick
Thomas H. Marwick